Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001209191-22-026450

Chief Financial Officer acquired 12,545 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Finley John David Chief Financial Officer 2022-04-29 Other acquisition +12,545 38,867 I
Loading xslF345X03/doc4.xml…